Envision Healthcare

Envision Healthcare Appoints Full Board of Directors to Support Next Chapter of Growth

Retrieved on: 
Thursday, January 11, 2024
Managed Care, General Health, Health, Practice Management, Bain & Company, Change Healthcare, Patient, UnitedHealth Group, Outline of health sciences, General counsel, ArcBest, Bridgewater Associates, Health care, Ethics, Justice, Stony Brook University, Envision, CFO, Policy, Envision Healthcare, CVS Health, Medicine, Bain, Gates Corporation, Executive, Interim management, Stolper, Interim, McKesson Corporation, Bank One Corporation, Ohio State University, Negotiation, RadNet, EVP, UHS, CSX Corporation, Growth, Management

Envision Healthcare, a leading national medical group, announced today the full appointment of its board of directors.

Key Points: 
  • Envision Healthcare, a leading national medical group, announced today the full appointment of its board of directors.
  • As Envision enters this next chapter, it remains focused on serving as a trusted provider of quality patient care and improving the health of communities.
  • Five directors join Steve Nelson and Henry Howe, who were recently appointed Chair of the Board of Directors, and Interim Chief Executive Officer (CEO) of Envision and Board Director, respectively, to complete the seven-member team.
  • “It is an honor to have such a talented and experienced group of healthcare leaders join our board,” Nelson said.

Envision Healthcare Renews In-Network Agreement With Blue Cross and Blue Shield of Texas

Retrieved on: 
Thursday, January 4, 2024
Professional Services, Health, Insurance, Practice Management, Health Insurance, Managed Care, Radiology, Blue Shield, Trauma, Health care, Blue Cross, Physician, Emergency medicine, Hospital medicine, Neonatology, Medicare, Patient, Envision Healthcare, Anesthesiology, Interim, Medicaid, Nursing care plan, Hospital

Envision Healthcare, a leading national medical group, has executed a multiyear, statewide agreement with Blue Cross and Blue Shield of Texas (BCBSTX), the state’s largest customer-owned health insurer, to provide its commercial, Managed Medicare and Managed Medicaid members in Texas with in-network care provided by Envision clinicians.

Key Points: 
  • Envision Healthcare, a leading national medical group, has executed a multiyear, statewide agreement with Blue Cross and Blue Shield of Texas (BCBSTX), the state’s largest customer-owned health insurer, to provide its commercial, Managed Medicare and Managed Medicaid members in Texas with in-network care provided by Envision clinicians.
  • The renewed agreement provides millions of BCBSTX members in Texas with in-network access to Envision physicians and advanced practice providers specializing in anesthesiology, emergency medicine, hospital medicine, neonatology, radiology, trauma and critical care.
  • “Our skilled and dedicated team of clinicians continue to innovate and advance the delivery of high-quality, patient-centered care,” said Henry Howe, Interim Chief Executive Officer of Envision Healthcare.
  • “We are pleased to build on our relationship with BCBSTX to address the evolving needs of the Texas community as it continues growing.

Equality Health Appoints Lawrence Green as Tennessee Market President to Deliver "Medicaid First" Value-Based Care Model to the State

Retrieved on: 
Thursday, November 9, 2023
Aurora, Accountable care organization, Nation, Advocate Aurora Health, Public policy, CIN, Health, Equalize Health, Region, Economics, University of Chicago, HCA Healthcare, Ascension (healthcare system), University of Illinois Urbana-Champaign, VBC, Learning, Medicaid, Envision Healthcare, University, PCP, Northern Illinois University, ACO, Nursing, Management, Northwestern University, Green

Equality Health equips participating independent PCPs with its proven value-based care platform -- including tools, technology and an activity-based financial model necessary to deliver enhanced services to vulnerable Medicaid members. Equality Health's care model, which aims to close care gaps, also augments care enablement with direct, community-based clinical services that extend the reach of PCPs into the places where the most clinically complex members live.

Key Points: 
  • Managed Care Executive with 30 Years of Experience at Nation's Largest Health Systems and Expertise in Creating Risk-Based Alternative Payment Models including Value-Based Care, Leads Team to Build-Out Equality Health in Tennessee
    NASHVILLE, Tenn., Nov. 9, 2023 /PRNewswire/ -- Equality Health, a national leader in value-based care, today announced the appointment of Lawrence Green to the role of Tennessee Market President.
  • Equality Health equips participating independent PCPs with its proven value-based care platform -- including tools, technology and an activity-based financial model necessary to deliver enhanced services to vulnerable Medicaid members.
  • He has led managed healthcare initiatives at the largest health systems in the nation including at Ascension Health, Advocate Aurora Health, and HCA Healthcare.
  • Health plans interested in more details about Equality Health's comprehensive value-based care model can learn more at the health plan resource page .

Envision Healthcare Begins CEO Transition, Appoints Board Chairman

Retrieved on: 
Monday, November 6, 2023
Health, Hospitals, Practice Management, Other Health, Managed Care, General Health, Military Open Simulator Enterprise Strategy, UnitedHealth Group, Insurance, Envision, Bridgewater Associates, Health care, Commercial and Government Entity code, Bain, Economics, Financial management, Georgetown University, Organization, Interim management, Bain & Company, University, Multimedia, Howe, Growth, COVID-19, Risk, Business administration, Commercial, Interim, Chenming Hu, Envision Healthcare, Bankruptcy, Portland State University, CFO, Master of Business Administration, Patient, Accounting, Bank One Corporation, State, Bachelor of Arts in Organizational Psychology, Management, Nursing

Envision Healthcare, a leading national medical group, announced today the appointment of Henry Howe as Interim Chief Executive Officer (CEO), effective December 1, 2023.

Key Points: 
  • Envision Healthcare, a leading national medical group, announced today the appointment of Henry Howe as Interim Chief Executive Officer (CEO), effective December 1, 2023.
  • Howe steps into this role as current Envision CEO Jim Rechtin transitions out of the organization at the end of November.
  • Envision also announced the appointment of healthcare industry veteran Steve Nelson to the position of Chairman of the Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20231106756041/en/
    Envision Healthcare announced the appointment of Henry Howe as Interim Chief Executive Officer (CEO), effective December 1, 2023.

US Anesthesia Drugs and Devices Market Set to Reach $6.83 Billion in 2023, Driven by Growing Healthcare Expenditure - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023
Pharmaceutical, Health, Medical Devices, Patient, Headache, Ageing, Anesthesiology, Pain, KKR, Vomiting, Abdominal ultrasonography, Somnolence, Prevalence, AstraZeneca, Conditional sentence, Lidocaine, Anesthetic, Shivering, MAC, Envision Healthcare, Nausea, 3M, Abbott Laboratories, General Electric Company, SunMed BRT station, Growth, Fungal infection, TeamHealth, COVID-19, Inhalation, Risk, AbbVie, Device, Benzocaine, Consciousness, Becton, Dickinson and Company headquarters, Blackstone, Braun, Baxter International, Ventilation, Central nervous system, ICU Medical, ICU, Pharmaceutical industry, Dentistry, Bupivacaine, Prilocaine, Anesthesia, Ropivacaine

The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.

Key Points: 
  • The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.
  • Among these segments, anesthesia drugs currently hold the majority share, while the anesthesia devices segment is expected to experience substantial growth due to increased healthcare expenditure in the region.
  • In terms of types, the US anesthesia drugs market is categorized into General, Local, and other anesthesia.
  • The development of novel anesthesia drugs through pharmaceutical R&D is expected to create growth opportunities in the "other anesthesia drugs" segment.

Envision Healthcare Successfully Emerges from Financial Restructuring Process

Retrieved on: 
Friday, November 3, 2023
General Health, Other Health, Hospitals, Health, Managed Care, United States bankruptcy court, Trust, Growth, Patient, Envision, Health care, Envision Healthcare, Corporate action, Pharmaceutical industry, Management

Envision Healthcare, a leading medical group, announced today it has successfully completed and emerged from its restructuring process with a markedly strengthened capital structure to support its growth as a leading medical group.

Key Points: 
  • Envision Healthcare, a leading medical group, announced today it has successfully completed and emerged from its restructuring process with a markedly strengthened capital structure to support its growth as a leading medical group.
  • In connection with emergence, Envision Healthcare and AMSURG separated into two stand-alone entities with separate leadership teams and owner groups.
  • “Envision continues to deliver high-performing services for our patients, hospital partners and the communities we serve,” said Envision Chief Executive Officer Jim Rechtin.
  • “Now that our financial restructuring has been completed successfully, we are driving Envision’s future growth from a position of stability and strength.

Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

Retrieved on: 
Monday, October 16, 2023
Medical Supplies, Retail, Health, Convenience Store, General Health, Pharmaceutical, Vitamins, Supplements, Chapter 11, Title 11, United States Code, NYSE, Acquisition, Rite, Risk management, Envision Healthcare, PwC, Rite Aid, Partner, Evergy, Interim, WeWork, Ascena Retail Group, Avaya, Growth, Accounting, Energy Future Holdings, Pharmacy, Frontier Communications, CFO, International Data Group, RAD, DXC Technology, GameStop, Management, Security (finance)

Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately.

Key Points: 
  • Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately.
  • Mr. Stein succeeds Elizabeth (“Busy”) Burr, who has served as Interim CEO of Rite Aid since January 2023.
  • Bruce Bodaken, Rite Aid Chairman, stated, “After a thorough and thoughtful search process, the Board unanimously agreed that Jeff is the right executive to lead Rite Aid through its transformation.
  • He has served as CEO, CFO, Chief Restructuring Officer and Chief Risk Officer at numerous companies, most recently as CEO of Energy Future Holdings.

Envision Healthcare Announces Successful Confirmation of Plans of Reorganization

Retrieved on: 
Wednesday, October 11, 2023
Health, Hospitals, Practice Management, Other Health, Managed Care, General Health, Envision, Bankruptcy, Chapter 11, Title 11, United States Code, Health care, LLP, PJT Partners, Envision Healthcare, Hearing, Growth, Kirkland & Ellis, United States bankruptcy court, Confirmation, Patient, Nursing

Envision Healthcare today announced that the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division has confirmed its Plans of Reorganization (the "Confirmed Plans").

Key Points: 
  • Envision Healthcare today announced that the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division has confirmed its Plans of Reorganization (the "Confirmed Plans").
  • Under the terms of the Confirmed Plans, which were approved at a hearing on October 11, 2023, Envision will eliminate 70 percent of its prepetition funded debt.
  • Importantly, the Confirmed Plans ensure that Envision and AMSURG will remain strong partners to their valued clinicians, physician partners, clients, vendors and suppliers following the reorganization.
  • “I am pleased to have reached an agreement with our key stakeholders and look forward to emerging from Chapter 11 in the coming weeks,” said Envision Healthcare CEO Jim Rechtin.

Humana Announces Leadership Transition Plan: Jim Rechtin named Chief Operating Officer and CEO Successor, Bruce Broussard to step down as CEO in the second half of 2024

Retrieved on: 
Wednesday, October 11, 2023
General Health, Health, Health Insurance, Envision, Senior, NYSE, Bachelor of Arts in Organizational Psychology, DePauw University, Envision Healthcare, Eberhardt Rechtin, Culture, Medicare Advantage, Medicare, Growth, UnitedHealth Group, Strategic management, MA, Business administration, Bain & Company, Harvard Business School, DaVita Inc., Master of Business Administration, Management, Nursing, Humana

(NYSE: HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition.

Key Points: 
  • (NYSE: HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition.
  • He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role.
  • Broussard joined Humana in 2011 and assumed the role of CEO in 2013.
  • “As we work to make this a seamless transition in the coming months, I look forward to partnering with Jim.

Bankruptcy Filings up to the 3rd quarter of 2023 exceed total filings for 2021 and 2022

Retrieved on: 
Thursday, October 5, 2023
Diamond, Aircraft, Medicine, Envision Healthcare, Real estate, Yellow Corporation, Environment, Bed, YTD, Chapter 15, Title 11, United States Code, Moelis & Company, Jefferies Group, Diamond Sports Group, Mallinckrodt, FTI, A&M, Chapter 22, Investment company, Western Global Airlines, Chapter 33 (G.I. Bill of Rights), Currency crisis, Jefferies, Investment banking, Health care, Evercore, Bankruptcy, Guggenheim, McDermott Will & Emery, Data, Amyris, Adviser, Guggenheim Partners, Sale, Multimedia, Dundon, Quarter, Huntsman Corporation, Mace Head Atmospheric Research Station, National CineMedia, Construction, Cryptocurrency, Liability

BOSTON, Oct. 5, 2023 /PRNewswire-PRWeb/ -- According to Data compiled by New Generation Research's BankruptcyData, Bankruptcy Filings as of the end of the Quarter ended September 31, 2023, totaled 7518 year to date. This is the highest rate of bankruptcy since 2020, up sharply from last year. The total number of filings YTD in 2023 exceeds all filings for both 2021 and 2022, and is on a pace which rivals the activity of 2020, itself was a record year unequaled since the days of the Global Financial Crisis.

Key Points: 
  • BOSTON, Oct. 5, 2023 /PRNewswire-PRWeb/ -- According to Data compiled by New Generation Research's BankruptcyData , Bankruptcy Filings as of the end of the Quarter ended September 31, 2023, totaled 7518 year to date.
  • So far in 2023, there have been such filings versus 383 for all of 2022, an increase of over 70%, and there are still three months to go in 2023.
  • Also, the number of companies doing a round trip to Bankruptcy court among public and large private companies has risen markedly in 2023.
  • The pace of filings has been trending upwards during the course of the year as the graph below indicates.